Teeraya Puavilai

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Autologous hematopoietic stem cell transplantation (auto-HSCT) is the standard treatment option for multiple myeloma (MM) and relapsed non-Hodgkin's lymphoma (NHL) patients. Granulocyte colony stimulating factor (G-CSF) combined with high-dose chemotherapy is a frequently used mobilization approach. 2 Chemo-mobilization success depends on the patient's age,(More)
BACKGROUND Thalidomide based regimen is an effective and well tolerated therapy in multiple myeloma (MM) patients, however, there were a small number of studies written about the results of thalidomide therapy in non-transplant MM patients. We therefore conducted a retrospective study of 42 consecutive patients with newly diagnosed and relapsed/refractory(More)
  • 1